Kagoshima City Hospital
Kagoshima 892-8580
1 studies enrolling now · 11 studies all time
What they study most
Cervical Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors, Intracerebral Hemorrhage, LGI1 Autoimmune Encephalitis, NMDAR Autoimmune Encephalitis, Ovarian Cancer, Primary Peritoneal Carcinoma, Primary Peritoneal Cavity Cancer
Studies at this site
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors — Running, not enrolling
- Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
- Study of Cemiplimab in Adults With Cervical Cancer — Completed
- Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial — Completed
- A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
- Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix — Stopped early